menu search

NWBO / Northwest Bio: Another Small Filing Delay

Northwest Bio: Another Small Filing Delay
Northwest Bio has provided a timeline for submitting an application for approval to the UK equivalent of the US FDA for their GBM therapy. The company has made significant progress in preparing the Marketing Authorization Application (MAA) for DCVax-L. NWBO plans to submit applications to multiple regulatory authorities and intends to provide updates at key milestones. Read More
Posted: Oct 14 2023, 02:29
Author Name: Seeking Alpha
Views: 111151

NWBO News  

Northwest Bio: Another Small Filing Delay

By Seeking Alpha
October 14, 2023

Northwest Bio: Another Small Filing Delay

Northwest Bio has provided a timeline for submitting an application for approval to the UK equivalent of the US FDA for their GBM therapy. The company more_horizontal

Northwest Bio: Is There Ever Going To Be A Right Time?

By Seeking Alpha
August 17, 2023

Northwest Bio: Is There Ever Going To Be A Right Time?

Northwest Biotherapeutics is a biotech focused on developing a dendritic cell vaccine to fight cancer. The company has faced financial challenges and more_horizontal

Biotech Firm Claims Citadel, Other Market Makers Manipulated Stock Price

By 24/7 Wall Street
December 1, 2022

Biotech Firm Claims Citadel, Other Market Makers Manipulated Stock Price

US biotech company Northwest Biotherapeutics filed a lawsuit against Citadel Securities and several other market makers, accusing them of lowering the more_horizontal

NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit

By InvestorPlace
December 1, 2022

NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit

Shares of Northwest Biotherapeutics (OTCMKTS: NWBO ) are in focus on Thursday. NWBO stock is up about 5% on the day and it's got investors' attention more_horizontal

Northwest Biotherapeutics: Data Is Done, Just Wait For Approval

By Seeking Alpha
November 23, 2022

Northwest Biotherapeutics: Data Is Done, Just Wait For Approval

NWBO published topline data on JAMA Oncology, resoundingly, I must say. Data shows stat sig on all major primary and secondary endpoints. more_horizontal

Northwest Bio: Buy Again, Wait For Regulatory Process

By Seeking Alpha
May 21, 2022

Northwest Bio: Buy Again, Wait For Regulatory Process

Data is excellent. I explain the bearish commentary here. more_horizontal

Northwest Bio: What A Comparison Analysis Says About Its Progress

By Seeking Alpha
March 5, 2022

Northwest Bio: What A Comparison Analysis Says About Its Progress

Northwest Bio: What A Comparison Analysis Says About Its Progress more_horizontal

Northwest Bio: What A Comparison Analysis Says About Its Progress

By Seeking Alpha
March 5, 2022

Northwest Bio: What A Comparison Analysis Says About Its Progress

Northwest Bio: What A Comparison Analysis Says About Its Progress more_horizontal


Search within

Pages Search Results: